Amarin Corp Plc (AMRN)

[sts66]

If the FDA relaxes the rules for Amarin, it is opening up the floodgates for every other company in Amarin's situation. From Amarin's standpoint, can they really believe the FDA will keep their end of the bargain. This sets up a situation where the FDA might later trap the company, claiming Amarin exceeded the agency's instructions and is guilty of deceptive advertising.

I warned about that last week, using it as rationale to state AMRN will not settle out of court - they need a legitimate court decision in their hands so the FDA can't entrap them later if they changed their minds on some handshake agreement.